These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8793049)

  • 1. Behavioral effects of naloxone infusion in obsessive-compulsive disorder.
    Keuler DJ; Altemus M; Michelson D; Greenberg B; Murphy DL
    Biol Psychiatry; 1996 Jul; 40(2):154-6. PubMed ID: 8793049
    [No Abstract]   [Full Text] [Related]  

  • 2. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK; McDougle CJ; Price LH; Barr LC; Hills OF; Caplik JF; Charney DS; Heninger GR
    Biol Psychiatry; 1995 Aug; 38(3):138-49. PubMed ID: 7578657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism.
    Mangold DL; Peyrot M; Giggey P; Wand GS
    Neuropsychopharmacology; 2000 Jun; 22(6):595-607. PubMed ID: 10788759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anger management style and emotional reactivity to noxious stimuli among chronic pain patients and healthy controls: the role of endogenous opioids.
    Bruehl S; Burns JW; Chung OY; Quartana P
    Health Psychol; 2008 Mar; 27(2):204-14. PubMed ID: 18377139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Maudsley Obsessive-Compulsive Stimuli Set: validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder.
    Mataix-Cols D; Lawrence NS; Wooderson S; Speckens A; Phillips ML
    Psychiatry Res; 2009 Aug; 168(3):238-41. PubMed ID: 19515429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroendocrine disturbances observed in obsessive compulsive disorders].
    Hantouche E; Olié JP
    Ann Med Psychol (Paris); 1992; 150(2-3):152-7. PubMed ID: 1343510
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone administration in obsessive-compulsive disorder: report of two cases.
    Insel TR; Pickar D
    Am J Psychiatry; 1983 Sep; 140(9):1219-20. PubMed ID: 6614234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of an opioid stimulatory tone on growth hormone secretion in women with microprolactinoma.
    Fanciulli G; Tomasi PA; Delitala G
    Endocr Res; 2008; 33(3):104-10. PubMed ID: 19156568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder and Jewish religiosity.
    Hermesh H; Masser-Kavitzky R; Gross-Isseroff R
    J Nerv Ment Dis; 2003 Mar; 191(3):201-3. PubMed ID: 12637849
    [No Abstract]   [Full Text] [Related]  

  • 11. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical obsessive-compulsive disorder in college students.
    Morris MR; Blashfield RK; Rankupalli B; Bradley MM; Goodman WK
    Depress Anxiety; 1996-1997; 4(5):233-6. PubMed ID: 9167789
    [No Abstract]   [Full Text] [Related]  

  • 13. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders.
    Halmi KA; Tozzi F; Thornton LM; Crow S; Fichter MM; Kaplan AS; Keel P; Klump KL; Lilenfeld LR; Mitchell JE; Plotnicov KH; Pollice C; Rotondo A; Strober M; Woodside DB; Berrettini WH; Kaye WH; Bulik CM
    Int J Eat Disord; 2005 Dec; 38(4):371-4. PubMed ID: 16231356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychophysiological and clinical value of event-related potentials in obsessive-compulsive disorder.
    Morault PM; Bourgeois M; Laville J; Bensch C; Paty J
    Biol Psychiatry; 1997 Jul; 42(1):46-56. PubMed ID: 9193741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interacting effects of trait anger and acute anger arousal on pain: the role of endogenous opioids.
    Bruehl S; Burns JW; Chung OY; Chont M
    Psychosom Med; 2011 Sep; 73(7):612-9. PubMed ID: 21862829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates and mediators of functional disability in obsessive-compulsive disorder.
    Storch EA; Abramowitz JS; Keeley M
    Depress Anxiety; 2009; 26(9):806-13. PubMed ID: 19170106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.
    Anholt GE; van Oppen P; Emmelkamp PM; Cath DC; Smit JH; van Dyck R; van Balkom AJ
    J Anxiety Disord; 2009 Aug; 23(6):830-5. PubMed ID: 19443176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive and eating disorders: comparison of clinical and personality features.
    Jiménez-Murcia S; Fernández-Aranda F; Raich RM; Alonso P; Krug I; Jaurrieta N; Alvarez-Moya E; Labad J; Menchón JM; Vallejo J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):385-91. PubMed ID: 17610663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.
    Remijnse PL; Nielen MM; van Balkom AJ; Hendriks GJ; Hoogendijk WJ; Uylings HB; Veltman DJ
    Psychol Med; 2009 Sep; 39(9):1503-18. PubMed ID: 19171077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood trauma and obsessive-compulsive symptoms.
    Mathews CA; Kaur N; Stein MB
    Depress Anxiety; 2008; 25(9):742-51. PubMed ID: 17557315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.